Translational Neuroscience, 2022 · DOI: https://doi.org/10.1515/tnsci-2022-0266 · Published: November 23, 2022
Spinal cord injury (SCI) can lead to serious motor deficits, and current treatments are insufficient. This study investigates acacetin, a natural compound with antioxidant and anti-inflammatory properties, as a potential treatment for SCI in mice. The researchers found that acacetin treatment improved motor function, protected nerve cells, and reduced inflammation and oxidative stress in mice with SCI. These beneficial effects appear to be linked to the activation of the Nrf2/HO-1 signaling pathway. By using an inhibitor of Nrf2, the study demonstrated that the neuroprotective effects of acacetin were reversed, highlighting the importance of this pathway in mediating acacetin's benefits for SCI.
Acacetin may serve as a novel therapeutic agent for SCI treatment due to its ability to alleviate neuroinflammation and oxidative stress.
The study identifies the Nrf2/HO-1 signaling pathway as a key target for therapeutic intervention in SCI, and acacetin's activation of this pathway contributes to its beneficial effects.
Further research is warranted to explore the specific molecular mechanisms by which acacetin mediates the Nrf2/HO-1 signaling pathway.